ATARA BIOTHERAPEUTICS INC ATRA
COM NEW · Common Stock · CUSIP 046513206 · ISIN US0465132068
Clinical-stage biotechnology company
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersThousand Oaks, CA
- Founded2012
- Websiteatarabio.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 7.0m as of 2025-08-06, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $7.72. Options: 1 managers hold calls ($0 notional), 1 hold puts ($0).
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2024 | 45 |
| Q3 2024 | 35 |
| Q4 2024 | 42 |
| Q1 2025 | 38 |
| Q2 2025 | 33 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 16 | 23 |
| Q4 2024 | 20 | 14 |
| Q1 2025 | 13 | 21 |
| Q2 2025 | 9 | 15 |
Biggest buyers
| MARSHALL WACE, LLP | New | +42.4k |
| CITADEL ADVISORS LLC | New | +23.0k |
| MACKENZIE FINANCIAL CORP | New | +22.5k |
| BlackRock, Inc. | Added | +10.1k |
| RAYMOND JAMES FINANCIAL INC | New | +4.0k |
| MORGAN STANLEY | Added | +3.1k |
| ROYAL BANK OF CANADA | Added | +2.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +1.5k |
| GSA CAPITAL PARTNERS LLP | Added | +206 |
Biggest sellers
| BANK OF AMERICA CORP /DE/ | Reduced | -179.6k |
| TANG CAPITAL MANAGEMENT LLC | Sold out | -75.2k |
| ACADIAN ASSET MANAGEMENT LLC | Reduced | -50.0k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -41.0k |
| Birchview Capital, LP | Sold out | -22.0k |
| UBS Group AG | Reduced | -15.9k |
| STALEY CAPITAL ADVISERS INC | Reduced | -5.0k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -500 |
| SVB WEALTH LLC | Sold out | -421 |
| Russell Investments Group, Ltd. | Sold out | -368 |
Biggest calls
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| EcoR1 Capital, LLC 13G · institution +7.5 pts · filed 2026-05-07 | 17.4% |
| Redmile Group, LLC 13D · may seek influence no change · filed 2026-07-24 | 9.9% |
| Panacea Innovation Ltd 13G · passive investor new · filed 2025-02-06 | 9.5% |
| Adage Capital Management, L.P. 13G · institution new · filed 2026-05-13 | 8.6% |
| Point72 Asset Management, L.P. 13G · passive investor +1.4 pts · filed 2026-08-14 | 7.6% |
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2023 | 0 | — | 6 | $120.6k | — |
| Q4 2023 | 3 | — | 6 | — | — |
| Q1 2024 | 0 | — | 5 | — | — |
| Q2 2024 | 0 | — | 5 | — | — |
| Q3 2024 | 0 | — | 5 | $53.4k | — |
| Q4 2024 | 0 | — | 3 | $45.1k | — |
| Q1 2025 | 0 | — | 3 | $39.2k | — |
| Q2 2025 | 0 | — | 2 | $37.1k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2025-05-16 | Nguyen AnhCo President and CEO, director | Sold | $22.1k3.3k shares |
| 2025-05-16 | Grant-Huerta Yanina Chief Accounting Officer | Sold | $15.0k2.2k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| EcoR1 Capital, LLC 0.26% of their portfolio | 573.2k $4.4m | Unchanged |
| Redmile Group, LLC 0.36% of their portfolio | 441.7k $3.4m | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 190.8k $1.5m | Unchanged |
| Vestal Point Capital, LP 0.04% of their portfolio | 94.1k $726.3k | Unchanged |
| STALEY CAPITAL ADVISERS INC 0.02% of their portfolio | 75.0k $579.0k | Reduced -5.0k |
| BlackRock, Inc. 0.00% of their portfolio | 70.8k $546.9k | Added +10.1k |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 65.2k $502.0k | Reduced -50.0k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 60.1k $464.3k | Added +1.5k |
| MARSHALL WACE, LLP 0.00% of their portfolio | 42.4k $327.0k | New |
| STATE STREET CORP 0.00% of their portfolio | 25.3k $195.0k | Unchanged |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 23.0k $177.6k | New |
| MACKENZIE FINANCIAL CORP 0.00% of their portfolio | 22.5k $173.8k | New |
| GSA CAPITAL PARTNERS LLP 0.01% of their portfolio | 19.6k $151.0k | Added +206 |
| FMR LLC 0.00% of their portfolio | 17.2k $132.4k | Reduced -1 |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 16.9k $130.7k | Reduced -500 |
| MORGAN STANLEY 0.00% of their portfolio | 14.9k $115.2k | Added +3.1k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 14.0k $108.1k | Unchanged |
| NORTHERN TRUST CORP 0.00% of their portfolio | 11.2k $86.2k | Unchanged |
| UBS Group AG 0.00% of their portfolio | 8.4k $64.7k | Reduced -15.9k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 7.7k $59.4k | Reduced -179.6k |
| RAYMOND JAMES FINANCIAL INC 0.00% of their portfolio | 4.0k $31.0k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 2.9k $24.0k | Added +2.0k |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 1.4k $10.8k | Unchanged |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 951 $7.3k | Unchanged |
| JONES FINANCIAL COMPANIES LLLP 0.00% of their portfolio | 703 $5.6k | Unchanged |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 216 $1.7k | Unchanged |
| Raiffeisen Bank International AG 0.00% of their portfolio | 200 $1.5k | Unchanged |
| Banque Transatlantique SA 0.00% of their portfolio | 176 $1.4k | Unchanged |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 175 $1.4k | Unchanged |
| GROUP ONE TRADING LLC 0.00% of their portfolio | 148 $1.1k | Unchanged |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 50 $386 | Unchanged |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 10 $77 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |